Federation des caisses Desjardins du Quebec’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-200	Closed	-$27.8K	–	2672
2021 Q3	$27.8K	Hold	200	–	–	﹤0.01%	1756
2021 Q2	$19.4K	Sell	200 -100	-33%	-$8.12K	﹤0.01%	1868
2021 Q1	$20.5K	Sell	300 -900	-75%	-$72.8K	﹤0.01%	1796
2020 Q4	$103K	Sell	1,200 -100	-8%	-$8.47K	﹤0.01%	1276
2020 Q3	$84.5K	Sell	1,300 -1,385	-52%	-$90.8K	﹤0.01%	1107
2020 Q2	$196K	Sell	2,685 -1,725	-39%	-$91.8K	﹤0.01%	851
2020 Q1	$150K	Buy	+4,410	New	+$202K	﹤0.01%	929

Other funds holding BHVN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's BHVN Position: Q4 2021 in Review

Federation des caisses Desjardins du Quebec sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2021, closing a stake of 200 shares — an estimated $27.8K sold.

Federation des caisses Desjardins du Quebec first reported a position in BHVN in Q1 2020 and held it in 7 quarters. The position peaked at $196K in Q2 2020. 284 funds tracked by Wall St. Rank hold BHVN as of Q4 2021.

Federation des caisses Desjardins du Quebec reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2021 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 200 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2021, an estimated $27.8K.
Federation des caisses Desjardins du Quebec first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2020 and held it in 7 quarters.
Federation des caisses Desjardins du Quebec's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $196K in Q2 2020.
284 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2021.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2021, filed 30 Aug 2024.